Please provide your email address to receive an email when new articles are posted on . Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

Overview The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing ...

Polares Medical has secured $50m through a Series C financing round to further support the development of its novel cardiac transcatheter implant, MRace, for patients with mitral regurgitation (MR).

Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032" report has been added to the Credence Research Inc.

SAN FRANCISCO, CA—Transcatheter mitral valve-in-valve procedures, especially those done via transseptal access, are associated with low mortality and adverse event rates as well as quality-of-life ...

Advances in the Treatment of Localized Prostate Cancer: The Role of Anatomic and Functional Imaging in Men Managed With Radiotherapy The purpose of this article is to present in a concise manner an ...

The first human transcatheter aortic valve implantation (TAVI) in 2002, and several subsequent single-center series, showed the feasibility of this new approach for the treatment of patients with ...